MYDECINE

MYDECINE

INNOVATIONS

Creating a healthier world through adaptive pathway medicines, natural health products and digital health solutions
CSX: MYCO | OTC: MYCOF | FRANKFURT: 0NF
X

Joshua Bartch
CEO

Please note this site is still under construction and some features may not be fully functional yet.

Our Mission

Our mission is to create a healthier world through advanced technologies, natural products, and psychedelic derived medicines. We were founded on the belief that innovation is needed to improve on existing products and mental health services. Our goal is to change the way you think about holistic health by delivering premium quality products and services that enhance your life.

Our Story

We started Mydecine Innovation with the goal of revolutionizing the way people live and experience life by offering cutting edge natural products and technologies. Our international team has been described as a collection of passionate business leaders, scientists, mental health professionals and technology visionaries.

We are inspired by the future, the innovators, the dreamers; and our products embody this  spirit. They are built for those that aspire to be healthy physically and spiritually while living life to the fullest and daring to disrupt the norm.

Our passion sent us on a mission to develop high quality products and disruptive new technologies so we can contribute to making the world a better place.
---VIDEO---

About Us

Mydecine Innovations Group is a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions.

Our Portfolio

Our Story

We started Mydecine Innovations Group with the goal of revolutionizing the way people live and experience life by offering cutting edge natural products and technologies. Our international team has been described as a collection of passionate business leaders, scientists, mental health professionals and technology visionaries.

We are inspired by the future, the innovators, the dreamers; and our products embody this  spirit. They are built for those that aspire to be healthy physically and spiritually while living life to the fullest and daring to disrupt the norm.

Our passion sent us on a mission to develop high quality products and disruptive new technologies so we can contribute to making the world a better place.
---VIDEO COMING SOON---

Our Brands

Mydecine is our core brand. We started Mydecine Innovation with the goal of revolutionizing the way people live and experience life by offering cutting edge natural products and technologies. Our international team has been described as a collection of passionate business leaders, scientists, mental health professionals and technology visionaries.
Kured was started with the goal of revolutionizing the way people live and experience life by offering cutting edge natural products and technologies. Our international team has been described as a collection of passionate business leaders, scientists, mental health professionals and technology visionaries.
Fresh CBD Water is infused with CBD, a naturally occurring cannabinoid in hemp, that has shown to have effects that include analgesic, anti-inflammatory, anti-oxidant, anti-emetic, anti-anxiety, anti-psyc
Mindleap Health was founded by purpose-driven leaders on a mission to enhance the wellbeing of millions of people that struggle with mental health problems. By combining traditional telemedicine, psychedelic medicine and advanced mood and behavior tracking and analytics, the Mindleap platform offers a powerful set of tools for managing mental healthcare.

For Investors

Ticker Symbols
CSX: MYCO
OTC: MYCOF
FRANKFURT: 0NF
SEDAR ProfileInvestor Presentation
See All News →

News & Media

Mydecine Innovations Group to Acquire NeuroPharm Inc.

June 10, 2020
Strategically Positioned on Therapies for Military, Veterans, Front-Line Personnel Globally to cope with Mental Health & Well-Being
Read More →

Mydecine Innovations Group Signs Definitive Agreement to Acquire Mindleap Health

June 17, 2020
Mydecine Innovations Group Inc. is pleased to announce that it has signed a definitive share exchange agreement with Mindleap Health Inc.
Read More →

Mydecine Innovations Group Inc. Signs Partnership Agreement With Applied Pharmaceutical Innovation

June 15, 2020
Hosted In The University Of Alberta Faculty Of Pharmacy And Pharmaceutical Sciences With Full Access To GMP Capacity And Health Canada Licenses
Read More →

Our Leadership

X

Joshua Bartch
CEO

Joshua Bartch - CEO, has a successful history in startups, cannabis as well as capital markets. Josh has successfully built and sold numerous successful companies ranging from tech to cannabis. Additionally, Josh has been instrumental in numerous M&A transactions as well as capital raising in the tens of millions.

X

Joshua Bartch
CEO

Damon Michaels - COO, has been heavily involved in the cannabis industry for over the past decade. Being a strong key management member of multiple large ventures within the cannabis space, Damon has been able to gain tremendous experience within the cannabis vertical from seed-to-sale and has built a massive network of resources. Damon’s last endeavor was with a company called ebbu which was the first dedicated company to the drug discovery of cannabinoids, which ultimately was acquired by Canopy Growth for CAD$429mm. Damon has also been involved in the action sports industry and also was one of four entrepreneurs to start Colorado's first ever glass recycling facility to focus on sustainable recycling.

X

Joshua Bartch
CEO

Robert Fletcher Roscow Jr. - CSO, is a biologist, entrepreneur, and inventor, who has worked extensively in the Cannabis biotech space. This work has included the filing of multiple patent applications, the sale of a start-up company and the administration of large research programs for an international publicly traded company. In addition to his scientific and business work Mr. Roscow has served as an industry stakeholder or expert for government panels on regulation in the US hemp industry.

X

Joshua Bartch
CEO

Jim Gunning - CMO, has an extensive and successful background in leadership and brand building. He was one of the first hires at Red Bull North America. In his 10 years with the brand he was an instrumental figure in their path to becoming a cultural phenomenon and to their hyper successful growth. He has since consulted and/or managed significant marketing programs with a multitude of brands from Target, Vitamin Water, Mattel to Jagermeister. His true passion is working with new brands in emerging categories.

X

Joshua Bartch
CEO

Michael Connolly - General Counsel/CCO, is a practicing attorney with 28 years of experience in the areas of corporate law, financial transactions, regulatory compliance, and business litigation both as in-house and as outside counsel for large national corporations and start-up companies. He has been involved in the cannabis and hemp/CBD industries for the past few years.

hello@mydecine.com
Subscribe to our newsletter
Thank you for subscribing.
Something went wrong while submitting the form.
Copyright © Mydecine Innovations Group Inc. 2020 | All rights reserved.
X

Our RSS Feed

Subscribe to the Mydecine RSS feed by pasting the following URL into an RSS reader:
http://mydecine-innovations-group.webflow.io/news/rss.xml